HMI Medical Expands Advanced Imaging Services to Strengthen Diagnostic Capabilities in Singapore
HMI Radiology (Novena) will deliver a full suite of diagnostic imaging services to aid in early detection and proactive health management in the community Integration of Siemens Healthineers high-resolution imaging systems and AI-enhanced workflows drives patient-centric innovation and broadens access to precision diagnostics across diverse clinical environments SINGAPORE, Oct....
Berlin Heals Welcomes Dr. Eric Fain as New Board Member
Berlin Heals adds MedTech Veteran Dr. Eric Fain to Board of Directors Dr. Fain brings over 35 years of strategic and start-up expertise Extensive experience in the Cardiovascular space particularly in active implants Led multiple successful financings and exits on both the strategic and start-up sides ZUG, Switzerland, Oct. 22,...
LISCure BioSciences Secures World’s First Approval for “Joint Health Probiotic” as Recognized Health Functional Ingredient
SEOUL, South Korea, Oct. 22, 2025 /PRNewswire/ -- LISCure BioSciences ("LISCure") announced that its proprietary joint health probiotic, JointWorks®, has been officially approved by the Korean Ministry of Food and Drug Safety (MFDS) as Recognized Health Functional Ingredient. This approval marks a historic milestone — JointWorks® is the world's first probiotic clinically proven to support joint health and remains...
ACM Biolabs Reports Favorable Safety Signals and Early Pharmacodynamics from Intramuscular Administration of ACM-CpG in Patients with Advanced Solid Tumors
SINGAPORE, Oct. 22, 2025 /PRNewswire/ -- ACM Biolabs, a clinical-stage biotechnology company developing next-generation nanoparticle-based immunotherapies, today announced encouraging early clinical findings from its ongoing Phase 1 study of ACM-CpG, a TLR9 agonist formulated with ACM's proprietary polymersome platform through a strategic collaboration with the National Cancer Centre Singapore (NCCS). Preclinical experiments show that the ACM nanoparticle formulation fundamentally alters CpG's...
Renalys Pharma Announces Support for Alport Syndrome Registry Study Organized by Japanese Society for Pediatric Nephrology
TOKYO, Oct. 22, 2025 /PRNewswire/ -- Renalys Pharma, Inc. (Headquarters: Chuo-ku, Tokyo; "Renalys") is pleased to announce the company is providing financial support for the Alport Syndrome Registry Study organized by the Japanese Society for Pediatric Nephrology (Head Office: Chiyoda-ku, Tokyo). The study is headed by Professor Kandai Nozu, Department of Pediatrics, Graduate School of Medicine, Kobe University....
Senna Wellness Retreat brings Mid-Autumn festival to 700 children in Sin Suoi Ho Commune, Lai Chau Province through the ‘Trăng Lên Đỉnh Núi’ campaign
BAC NINH, Vietnam, Oct. 22, 2025 /PRNewswire/ -- Senna Wellness Retreat has successfully completed 'Trăng Lên Đỉnh Núi' (Moonrise over the mountain) campaign with a charitable trip to Sin Suoi Ho Commune, Lai Chau Province on October 02, 2025. The visit marked the completion of a two-month journey dedicated to bringing a meaningful Mid-Autumn Festival to children and local...
WuXi Biologics Included in Hang Seng Corporate Sustainability Benchmark Index
The only company from pharmaceutical industry selected for inclusion in the Index Also included in HSI ESG Index and Hang Seng ESG 50 Index Green CRDMO solution provider with outstanding sustainability performance HONG KONG, Oct. 22, 2025 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced its inclusion in...
The Shaw Prize Award Presentation Ceremony 2025: Continuing 22 Years of Legacy in Science and Innovation
HONG KONG, Oct. 22, 2025 /PRNewswire/ -- The Shaw Prize presented its awards to four 2025 Shaw Laureates on 21 Oct at the 2025 Award Presentation Ceremony, held in the Grand Hall of the Hong Kong Convention and Exhibition Centre. Approximately 600 guests from various sectors participated in the event. (From left to right) Professor Kenji Fukaya, Professor...
AESOP Technology announces DxPrime is now a qualified solution on Mayo Clinic Platform
SAN FRANCISCO, Oct. 21, 2025 /PRNewswire/ -- DxPrime, an AI-powered solution designed to enhance diagnostic accuracy through real-time integrity analysis and automated code translation, is now available on Mayo Clinic Platform. Driven by AESOP Technology's Clinical Deep Reasoning Network Model, DxPrime customizes its insights based on specialty, gender, and clinical context to ensure diagnostic completeness and precision. It delivers...
Charming Medical Limited Announces Pricing of Initial Public Offering and Listing on Nasdaq
HONG KONG, Oct. 21, 2025 /PRNewswire/ -- Charming Medical Limited (Nasdaq: MCTA) (the "Company"), a Hong Kong-based provider of Traditional Chinese Medicine (TCM)-inspired therapies and products, today announced the pricing of its initial public offering (the "Offering") of 1,600,000 Class A ordinary shares, par value $0.0001 per share (the "Class A Ordinary Shares") at a price of $4.00 per share...
